Elena Rodríguez-González, Pablo Martínez-Legazpi, Teresa Mombiela, Ana González-Mansilla, Antonia Delgado-Montero, Juan A Guzmán-De-Villoria, Fernando Díaz-Otero, Raquel Prieto-Arévalo, Miriam Juárez, María Del Carmen García Del Rey, Pilar Fernández-García, Óscar Flores, Andrea Postigo, Raquel Yotti, Manuel García-Villalba, Francisco Fernández-Avilés, Juan C Del Álamo, Javier Bermejo
INTRODUCTION AND OBJECTIVES: In the setting of ST-segment elevation myocardial infarction (STEMI), imaging-based biomarkers could be useful for guiding oral anticoagulation to prevent cardioembolism. Our objective was to test the efficacy of intraventricular blood stasis imaging in predicting a composite primary endpoint of cardioembolic risk during the first 6 months after STEMI. METHODS: We designed a prospective clinical study, Imaging Silent Brain Infarct in Acute Myocardial Infarction (ISBITAMI, NCT02917213), including patients with a first STEMI, an ejection fraction ≤ 45% and without atrial fibrillation to assess the performance of stasis metrics to predict cardioembolism...
May 8, 2024: Revista Española de Cardiología